AN2 Therapeutics Director Margaret FitzPatrick Buys Shares

What Happened
Margaret M. FitzPatrick, a director of AN2 Therapeutics, purchased 2,098 shares of AN2 (ANTX) on 2026-09-01 at $5.53 per share, for a total reported cost of $11,602. The Form 4 lists the transaction as a purchase (code P), described as an open-market or private purchase. Purchases are direct acquisitions of stock and are often watched by investors as a possible positive signal, though motivations are not disclosed.

Key Details

• Transaction date: 2026-09-01
• Price and quantity: 2,098 shares at $5.53 per share (total $11,602)
• Transaction type: Purchase (code P) — open-market or private purchase as reported
• Filing date: 2026-09-02 (appears timely — Form 4s must generally be filed within two business days)
• Shares owned after transaction: Not specified in the information provided in this summary
• Footnotes/plan indicators: None noted in the provided data (no 10b5-1 plan, tax-withholding, or other special footnotes reported)

Context
This was a straightforward buy rather than an option exercise, gift, or sale. The purchase size (~$11.6k) is modest in dollar terms for an insider transaction; such buys can attract attention but do not by themselves confirm a change in company outlook or insider sentiment. Investors should consider this alongside other filings, company news, and financials.